Access
This article is part of Nature's premium content.
Published online 8 October 2008 | Nature 455, 718 (2008) | doi:10.1038/455718a
News: Q&A
The future for Howard Hughes
Robert Tjian speaks to Nature about his plans as the new president of the Howard Hughes Medical Institute.
Robert Tjian is a biochemist and molecular biologist at the University of California, Berkeley, who has made significant discoveries about DNA transcription factors. He co-founded the biotechnology company Tularik, which was sold in 2003 for US$1.
To read this story in full you will need to login or make a payment (see right).
Comments
Reader comments are usually moderated after posting. If you find something offensive or inappropriate, you can speed this process by clicking 'Report this comment' (or, if that doesn't work for you, email redesign@nature.com). For more controversial topics, we reserve the right to moderate before comments are published.
